The United States will ship approximately 80 million excess doses of COVID-19 vaccines abroad; Ireland's health services system could be hobbled for weeks by a ransomware attack; the FDA recalls more than 60,000 pacemakers manufactured by Abbott.
President Joe Biden announced that the United States will ship approximately 20 million doses of excess Pfizer, Moderna, and Johnson & Johnson COVID-19 vaccines to in need countries abroad. Reported by NPR, shipments will also include 60 million AstraZeneca vaccines currently in the US total reserve, which has yet to be authorized for use in the United States. Distribution is planned to be completed by the end of June.
It could be weeks before the Irish health system returns to normal in the wake of a cyberattack, the Associated Press reported. The attack happened on Friday and a Russian-speaking hacking group has demanded $20 million, the report said. The ransomware attack has forced the disruption of care involving diagnostic appointments, cancer treatment, and surgeries; in addition, health care workers cannot get paid.
Due to the risk of electrical shorts and reduced battery life associated with Assurity and Endurity implantable pacemakers manufactured by Abbott, the FDA issued a Class 1 recall, the most serious type of recall, of nearly 62,000 pacemakers that were distributed between April 2015 and February 2019. Reported by Fox News, the devices have been linked with 135 complaints and 135 injuries, but no deaths have been reported.
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Shaping Dermatology's Future by Increasing Access, Data, and Advocacy
March 7th 2025Thy N. Huynh, MD, FAAD, Bruce A. Brod, MHCI, MD, FAAD, and Melissa Piliang, MD, FAAD, discussed expanding access to pediatric dermatology, dermatology data aggregation, and advocacy for Medicare physician payment reform, respectively.
Read More